The construction of a highly potent API laboratory to ensure operator and environmental safety has been initiated in 2022 to extend our in-house technical capabilities for new product developments.

The 100 m2 dedicated suite for highly potent products will become operational by the end of the calendar year and the forthcoming inspection by the Greek Regulatory Authorities will certify GMP compliance.

The steadily increasing demand for new products containing active substances categorized as highly potent, such as medicines to treat cancer, resulted in the strategic decision of allocating resources and in this fast-growing area.